Show simple item record

Files in this item

Thumbnail

Item metadata

dc.contributor.authorSessolo, Abdulwahab
dc.contributor.authorMusisi, Emmanuel
dc.contributor.authorKaswabuli, Sylvia
dc.contributor.authorZawedde, Josephine
dc.contributor.authorByanyima, Patrick
dc.contributor.authorSabiiti, Wilber
dc.contributor.authorWalimbwa, Stanley
dc.contributor.authorOla, Joseph
dc.contributor.authorSanyu, Ingvar
dc.contributor.authorLalitha, Rejani
dc.contributor.authorKamya, Moses
dc.contributor.authorDavis, Lucian
dc.contributor.authorWorodria, William
dc.contributor.authorHuang, Laurence
dc.date.accessioned2023-04-25T12:30:12Z
dc.date.available2023-04-25T12:30:12Z
dc.date.issued2023-04-21
dc.identifier284109861
dc.identifierb38e7129-defe-46e7-886d-5818367f6b26
dc.identifier85153540644
dc.identifier.citationSessolo , A , Musisi , E , Kaswabuli , S , Zawedde , J , Byanyima , P , Sabiiti , W , Walimbwa , S , Ola , J , Sanyu , I , Lalitha , R , Kamya , M , Davis , L , Worodria , W & Huang , L 2023 , ' Diagnostic accuracy of Xpert MTB/RIF Ultra and culture assays to detect Mycobacterium Tuberculosis using OMNIgene-sputum processed stool among adult TB presumptive patients in Uganda ' , PLoS One , vol. 18 , no. 4 , e0284041 . https://doi.org/10.1371/journal.pone.0284041en
dc.identifier.issn1932-6203
dc.identifier.otherORCID: /0000-0002-4742-2791/work/133736518
dc.identifier.urihttps://hdl.handle.net/10023/27466
dc.descriptionFunding: This study was funded by The Academy for Health Innovation Uganda (RFA 003/2017, awarded to AS) through the Infectious Disease Institute of Makerere University. The parent study in which our study was nested was funded by the National Heart, Lung, and Blood Institute under the I AM OLD grant (2R01HL128156-05A1, awarded to LH) through Professor Laurence Huang of University of California San Francisco. The IAM OLD grant provided the funding to support participant enrolment. DNAgenotek Inc. the manufacturers of the OMNIgene. SPUTUM provided the reagent free of charge, received by AS.en
dc.description.abstractBackground Stool is a potential sample for diagnosing Mycobacterium tuberculosis (Mtb) in patients with difficulty in expectorating. However, high mycobacterial culture contamination rates and Xpert MTB/RIF Ultra test error rates on stool samples have limited its use. OMNIgene SPUTUM (OM-S) is a sample transport reagent with characteristics of sputum decontamination while maintaining viable Mtb. We evaluated the impact of OM-S on Mtb diagnostic yield from stool using smear microscopy, Xpert MTB/RIF Ultra, and culture among presumptive TB patients. Methods Paired stool and expectorated sputum samples were collected from consecutive Ugandan adults undergoing diagnostic evaluation for pulmonary TB between June 2018 and June 2019. Stool was divided into 2 portions: one was homogenized in OM-S (OM-S stool) and the other in PBS (PBS stool) as control. Both sputum and processed stool were tested for Mtb using concentrated smear fluorescence microscopy (CFM), Xpert MTB/RIF Ultra (Xpert) and Mycobacteria Growth Indicator Tube (MGIT) culture. Sensitivity, specificity, and predictive values for each test were calculated against sputum MGIT culture as the reference standard. Results Of the 200 participants, 120 (60%) were male, 73 (37%) were HIV positive (median CD4 120 cells/uL (IQR 43–297)) and 128 (64%) had confirmed pulmonary TB by sputum MGIT culture. Seven (4%) OM-S stool Xpert samples reported errors while 47 (25%) and 103 (61%) were contaminated on OM-S stool MGIT and PBS stool MGIT, respectively. OM-S stool MGIT was able to accurately diagnose 56 of the contaminated PBS stool MGIT samples compared to only 5 of the contaminated OM-S stool MGIT samples diagnosed by PBS stool MGIT. Sensitivity (95% Confidence Interval, CI) 89% (83–94) for OM-S stool Xpert was higher compared to that of OM-S stool MGIT 60% (51–69) and PBS stool MGIT 42% (32–52). Specificity (95%CI) 91% (82–97) was also higher for OM-S stool Xpert compared to OM-S stool MGIT 64% (51–75) and PBS stool MGIT 26% (16–38). Conclusion Stool processed with OM-S showed potential to improve Mtb diagnostic yield and reduce rates of indeterminate results when tested on Xpert and MGIT culture. The method may thus be of value in Mtb detection among patients with difficulty to expectorate.
dc.format.extent14
dc.format.extent1001540
dc.language.isoeng
dc.relation.ispartofPLoS Oneen
dc.subjectRC Internal medicineen
dc.subjectDASen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectMCCen
dc.subject.lccRCen
dc.titleDiagnostic accuracy of Xpert MTB/RIF Ultra and culture assays to detect Mycobacterium Tuberculosis using OMNIgene-sputum processed stool among adult TB presumptive patients in Ugandaen
dc.typeJournal articleen
dc.contributor.institutionUniversity of St Andrews. Infection and Global Health Divisionen
dc.contributor.institutionUniversity of St Andrews. School of Medicineen
dc.identifier.doi10.1371/journal.pone.0284041
dc.description.statusPeer revieweden


This item appears in the following Collection(s)

Show simple item record